HSI Gains 174 Pts at Half-day; XIAOMI-W Up 4%; INNOVENT BIO Swells 8%+ Post-results; SHENZHOU INTL Dives 7%+
I'm LongbridgeAI, I can summarize articles.The Hang Seng Index rose 174 points to close the half-day session at 25,685. Tech stocks gained broadly, with Xiaomi up 4% following new chip announcements and Alibaba rising on increased insider buying. Innovative drug stocks surged, led by Innovent Bio's 8% jump after strong interim profits. Conversely, Shenzhou International plunged over 7% due to missed gross margin expectations, while WuXi series stocks faced pressure despite positive analyst actions.
This morning (26th), the HSI opened up 124 pts and closed the half-day session at 25,685, up 174 pts or 0.68%, with market turnover at HKD139.917 billion. The HSCEI concluded at 8,549, up 104 pts or 1.23%, while the HSTECH finished at 4,660, up 72 pts or 1.58%.
Major tech stocks were broadly higher. BABA-W (09988.HK) +1.700 (+1.489%) Short selling $1.52B; Ratio 22.716% grew 1.49% amid reports that Jack Ma increased his holdings by more than HKD600 million over recent days. MEITUAN-W (03690.HK) +1.700 (+2.202%) Short selling $302.79M; Ratio 24.986% rebounded 2.2%. BIDU-SW (09888.HK) +1.250 (+1.393%) Short selling $59.92M; Ratio 16.610% gained 1.4%, while NTES (09999.HK) -3.200 (-1.608%) Short selling $411.02M; Ratio 45.212% lost 1.6%. TENCENT (00700.HK) +4.400 (+0.995%) Short selling $468.70M; Ratio 12.830% climbed 1%. XIAOMI-W (01810.HK) +1.200 (+4.323%) Short selling $567.54M; Ratio 23.421% advanced 4.32% after unveiling its new-generation Xring chip.
Some innovative drug stocks soared. INNOVENT BIO (01801.HK) +8.400 (+8.392%) Short selling $560.59M; Ratio 20.475% surged 8.39% after reporting a 50% rise in interim profit, making it the best-performing blue chip in the morning session. CANSINOBIO (06185.HK) +5.280 (+18.644%) Short selling $23.39M; Ratio 3.687% swelled 18.64% after signing a strategic cooperation framework agreement for the joint development of mRNA personalized therapeutic cancer vaccines. EVEREST MED (01952.HK) +1.860 (+5.049%) Short selling $21.88M; Ratio 2.348% spiked 5.05%. CSPC PHARMA (01093.HK) +0.180 (+1.913%) Short selling $161.01M; Ratio 14.476% added 1.91% after interim profit jumped nearly 1.4x. However, WuXi series came under pressure. WUXI BIO (02269.HK) -0.700 (-1.341%) Short selling $322.82M; Ratio 10.992% faded 1.34% after results. WUXI XDC (02268.HK) -2.650 (-3.306%) Short selling $51.62M; Ratio 13.095% , whose TP was raised by CLSA, lost 3.31% by midday. WUXI APPTEC (02359.HK) -4.400 (-2.155%) Short selling $224.28M; Ratio 30.469% tumbled 2.15%.
Among blue chips, NONGFU SPRING (09633.HK) -0.540 (-1.255%) Short selling $119.20M; Ratio 47.951% shrank 1.25% despite interim net profit adding 16.6% and beating expectations. LAOPU GOLD (06181.HK) +13.000 (+3.335%) Short selling $80.59M; Ratio 15.128% leaped 3.34% after announcing ambitious overseas expansion plans for next year. SHENZHOU INTL (02313.HK) -3.040 (-7.389%) Short selling $147.98M; Ratio 33.568% plunged 7.39% to HKD38.1, hitting a more than 10-year trough and becoming the worst-performing blue chip of the morning, as brokers said its 1H gross margin missed. HAIDILAO (06862.HK) +0.720 (+6.310%) Short selling $84.91M; Ratio 32.858% elevated 6.31% after 1H core operating profit lifted 4.4%.
(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-08-26 12:25.)